A detailed history of Mjp Associates Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Mjp Associates Inc holds 4,763 shares of ABBV stock, worth $969,508. This represents 0.17% of its overall portfolio holdings.

Number of Shares
4,763
Previous 4,899 2.78%
Holding current value
$969,508
Previous $892,000 8.52%
% of portfolio
0.17%
Previous 0.19%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

SELL
$154.79 - $180.76 $21,051 - $24,583
-136 Reduced 2.78%
4,763 $816,000
Q1 2024

Apr 11, 2024

BUY
$159.82 - $182.1 $117,627 - $134,025
736 Added 17.68%
4,899 $892,000
Q4 2023

Jan 18, 2024

SELL
$137.6 - $154.97 $95,494 - $107,549
-694 Reduced 14.29%
4,163 $645,000
Q3 2023

Oct 10, 2023

SELL
$133.59 - $154.65 $19,904 - $23,042
-149 Reduced 2.98%
4,857 $723,000
Q2 2023

Jul 11, 2023

SELL
$132.51 - $164.9 $430,922 - $536,254
-3,252 Reduced 39.38%
5,006 $674,000
Q1 2023

Apr 17, 2023

BUY
$144.61 - $166.54 $52,638 - $60,620
364 Added 4.61%
8,258 $1.32 Million
Q4 2022

Jan 20, 2023

BUY
$138.31 - $165.87 $69,984 - $83,930
506 Added 6.85%
7,894 $0
Q3 2022

Oct 12, 2022

SELL
$134.21 - $153.93 $31,673 - $36,327
-236 Reduced 3.1%
7,388 $992,000
Q2 2022

Jul 11, 2022

BUY
$137.62 - $174.96 $14,037 - $17,845
102 Added 1.36%
7,624 $1.17 Million
Q1 2022

Apr 19, 2022

BUY
$131.98 - $163.75 $139,898 - $173,575
1,060 Added 16.4%
7,522 $1.22 Million
Q4 2021

Jan 18, 2022

BUY
$107.43 - $135.93 $81,324 - $102,899
757 Added 13.27%
6,462 $875,000
Q3 2021

Oct 13, 2021

BUY
$106.4 - $120.78 $32,026 - $36,354
301 Added 5.57%
5,705 $615,000
Q2 2021

Jul 14, 2021

BUY
$105.21 - $117.21 $43,030 - $47,938
409 Added 8.19%
5,404 $609,000
Q1 2021

May 04, 2021

BUY
$102.3 - $112.62 $23,938 - $26,353
234 Added 4.91%
4,995 $541,000
Q4 2020

Jan 27, 2021

BUY
$80.49 - $108.67 $383,212 - $517,377
4,761 New
4,761 $510,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $360B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Mjp Associates Inc Portfolio

Follow Mjp Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mjp Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mjp Associates Inc with notifications on news.